{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:11:04Z","timestamp":1792800664620,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fundamental Research Funds for the Central Public Welfare Research Institutes","award":["YZX-202323"],"award-info":[{"award-number":["YZX-202323"]}]},{"name":"Fundamental Research Funds for the Central Public Welfare Research Institutes","award":["YPX-202301"],"award-info":[{"award-number":["YPX-202301"]}]},{"name":"TCM Theory Inheritance and Innovation Project of CACMS Innovation Fund","award":["KYG-202402"],"award-info":[{"award-number":["KYG-202402"]}]},{"name":"TCM Theory Inheritance and Innovation Project of CACMS Innovation Fund","award":["KYG-202405"],"award-info":[{"award-number":["KYG-202405"]}]},{"name":"Scientific and Technological Innovation Project, China Academy of Chinese Medical Sciences","award":["CI2021A00112"],"award-info":[{"award-number":["CI2021A00112"]}],"id":[{"id":"https:\/\/ror.org\/042pgcv68","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Beijing Traditional Chinese Medicine Technology Development Foundation","award":["BJZYYB-2023-18"],"award-info":[{"award-number":["BJZYYB-2023-18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-02860-3","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T22:01:36Z","timestamp":1727474496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ethosomes-mediated tryptanthrin delivery as efficient anti-psoriatic nanotherapy by enhancing topical drug absorption and lipid homeostasis"],"prefix":"10.1186","volume":"22","author":[{"given":"Pengyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinnan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruodan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"19","key":"2860_CR1","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1001\/jama.2022.5270","volume":"327","author":"K Walter","year":"2022","unstructured":"Walter K. Psoriasis. JAMA. 2022;327(19):1936. https:\/\/doi.org\/10.1001\/jama.2022.5270.","journal-title":"JAMA"},{"issue":"5","key":"2860_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J, Psoriasis. N Engl J Med. 2009;361(5):496\u2013509. https:\/\/doi.org\/10.1056\/NEJMra0804595.","journal-title":"N Engl J Med"},{"key":"2860_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Suarez-Farinas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227\u201355. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120225.","journal-title":"Annu Rev Immunol"},{"issue":"9997","key":"2860_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Schon MP, Psoriasis. Lancet. 2015;386(9997):983\u201394. https:\/\/doi.org\/10.1016\/S0140-6736(14)61909-7.","journal-title":"Lancet"},{"issue":"10281","key":"2860_CR5","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J, Psoriasis. Lancet. 2021;397(10281):1301\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6.","journal-title":"Lancet"},{"issue":"3","key":"2860_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140(3):645\u201353. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.004.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2860_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaad.2020.03.033","volume":"83","author":"E Dauden","year":"2020","unstructured":"Dauden E, Carretero G, Rivera R, Ferrandiz C, Llamas-Velasco M, de la Cueva P, Belinchon I, Gomez-Garcia FJ, Herrera-Acosta E, Ruiz-Genao DP, et al. Long-term safety of nine systemic medications for psoriasis: a cohort study using the Spanish Registry of adverse events for Biological Therapy in Dermatological diseases (BIOBADADERM) Registry. J Am Acad Dermatol. 2020;83(1):139\u201350. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.033.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"2860_CR8","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.drudis.2020.09.023","volume":"25","author":"VK Rapalli","year":"2020","unstructured":"Rapalli VK, Waghule T, Gorantla S, Dubey SK, Saha RN, Singhvi G. Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems. Drug Discov Today. 2020;25(12):2212\u201326. https:\/\/doi.org\/10.1016\/j.drudis.2020.09.023.","journal-title":"Drug Discov Today"},{"issue":"4","key":"2860_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1517\/17425247.2015.982088","volume":"12","author":"M Rahman","year":"2015","unstructured":"Rahman M, Akhter S, Ahmad J, Ahmad MZ, Beg S, Ahmad FJ. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy. Expert Opin Drug Deliv. 2015;12(4):635\u201352. https:\/\/doi.org\/10.1517\/17425247.2015.982088.","journal-title":"Expert Opin Drug Deliv"},{"key":"2860_CR10","doi-asserted-by":"publisher","unstructured":"Li N, Qin Y, Dai D, Wang P, Shi M, Gao J, Yang J, Xiao W, Song P, Xu R. Transdermal Delivery of Therapeutic Compounds with Nanotechnological approaches in Psoriasis. Front Bioeng Biotechnol. 2022;9. https:\/\/doi.org\/10.3389\/fbioe.2021.804415.","DOI":"10.3389\/fbioe.2021.804415"},{"issue":"sup1","key":"2860_CR11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/21691401.2018.1431650","volume":"46","author":"NR Khan","year":"2018","unstructured":"Khan NR, Wong TW. 5-Fluorouracil ethosomes - skin deposition and melanoma permeation synergism with microwave. Artif Cells Nanomed Biotechnol. 2018;46(sup1):568\u201377. https:\/\/doi.org\/10.1080\/21691401.2018.1431650.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"2860_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/08982104.2018.1556292","volume":"29","author":"MR Peram","year":"2019","unstructured":"Peram MR, Jalalpure S, Kumbar V, Patil S, Joshi S, Bhat K, Diwan P. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: in vitro evaluation. J Liposome Res. 2019;29(3):291\u2013311. https:\/\/doi.org\/10.1080\/08982104.2018.1556292.","journal-title":"J Liposome Res"},{"key":"2860_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s41232-018-0089-2","volume":"38","author":"M Murakami","year":"2018","unstructured":"Murakami M, Yamamoto K, Taketomi Y, Phospholipase. A(2) in skin biology: new insights from gene-manipulated mice and lipidomics. Inflamm Regen. 2018;38:31. https:\/\/doi.org\/10.1186\/s41232-018-0089-2. From NLM.","journal-title":"Inflamm Regen"},{"issue":"11","key":"2860_CR14","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid NanoparticlesFrom liposomes to mRNA vaccine delivery, a Landscape of Research Diversity and Advancement. ACS Nano. 2021;15(11):16982\u20137015. PubMedhttps:\/\/doi.org\/10.1021\/acsnano.1c04996.","journal-title":"ACS Nano"},{"issue":"1","key":"2860_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.plipres.2012.10.003","volume":"52","author":"AC Kendall","year":"2013","unstructured":"Kendall AC, Nicolaou A. Bioactive lipid mediators in skin inflammation and immunity. Prog Lipid Res. 2013;52(1):141\u201364. https:\/\/doi.org\/10.1016\/j.plipres.2012.10.003.","journal-title":"Prog Lipid Res"},{"key":"2860_CR16","doi-asserted-by":"publisher","first-page":"1029818","DOI":"10.3389\/fimmu.2022.1029818","volume":"13","author":"CC Zouboulis","year":"2022","unstructured":"Zouboulis CC, Coenye T, He L, Kabashima K, Kobayashi T, Niemann C, Nomura T, Ol\u00e1h A, Picardo M, Quist SR, et al. Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations. Front Immunol. 2022;13:1029818. PubMedhttps:\/\/doi.org\/10.3389\/fimmu.2022.1029818.","journal-title":"Front Immunol"},{"key":"2860_CR17","doi-asserted-by":"publisher","first-page":"1094375","DOI":"10.3389\/fimmu.2022.1094375","volume":"13","author":"Y Kong","year":"2022","unstructured":"Kong Y, Jiang J, Huang Y, Liu X, Jin Z, Li L, Wei F, Liu X, Yin J, Zhang Y, et al. Narciclasine inhibits phospholipase A2 and regulates phospholipid metabolism to ameliorate psoriasis-like dermatitis. Front Immunol. 2022;13:1094375. PubMedhttps:\/\/doi.org\/10.3389\/fimmu.2022.1094375.","journal-title":"Front Immunol"},{"issue":"6","key":"2860_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/MOL.0b013e32833f2fcb","volume":"21","author":"E Feige","year":"2010","unstructured":"Feige E, Mendel I, George J, Yacov N, Harats D. Modified phospholipids as anti-inflammatory compounds. Curr Opin Lipidol. 2010;21(6):525\u20139. https:\/\/doi.org\/10.1097\/MOL.0b013e32833f2fcb.","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"2860_CR19","doi-asserted-by":"publisher","first-page":"e15335","DOI":"10.1111\/dth.15335","volume":"35","author":"S Karapetyan","year":"2022","unstructured":"Karapetyan S, Davtyan H, Khachikyan K, Hakobyan G. Impact of supplemental essential phospholipids on treatment outcome and quality of life of patients with psoriasis with moderate severity. Dermatol Ther. 2022;35(4):e15335. https:\/\/doi.org\/10.1111\/dth.15335.","journal-title":"Dermatol Ther"},{"issue":"3","key":"2860_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000348865","volume":"26","author":"A Farkas","year":"2013","unstructured":"Farkas A, Kemeny L. Alcohol, liver, systemic inflammation and skin: a focus on patients with psoriasis. Skin Pharmacol Physiol. 2013;26(3):119\u201326. https:\/\/doi.org\/10.1159\/000348865.","journal-title":"Skin Pharmacol Physiol"},{"issue":"5 Suppl","key":"2860_CR21","doi-asserted-by":"publisher","first-page":"S245","DOI":"10.1177\/1091581812461381","volume":"31","author":"MM Fiume","year":"2012","unstructured":"Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG Jr., Shank RC, Slaga TJ, Snyder PW, et al. Safety assessment of propylene glycol, tripropylene glycol, and PPGs as used in cosmetics. Int J Toxicol. 2012;31(5 Suppl):S245\u201360. https:\/\/doi.org\/10.1177\/1091581812461381.","journal-title":"Int J Toxicol"},{"issue":"10","key":"2860_CR22","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1211\/jpp.59.10.0017","volume":"59","author":"MM Elsayed","year":"2007","unstructured":"Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. PG-liposomes: novel lipid vesicles for skin delivery of drugs. J Pharm Pharmacol. 2007;59(10):1447\u201350. https:\/\/doi.org\/10.1211\/jpp.59.10.0017.","journal-title":"J Pharm Pharmacol"},{"key":"2860_CR23","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2147\/ijn.S105016","volume":"11","author":"IM Abdulbaqi","year":"2016","unstructured":"Abdulbaqi IM, Darwis Y, Khan NA, Assi RA, Khan AA. Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomed. 2016;11:2279\u2013304. https:\/\/doi.org\/10.2147\/ijn.S105016. From NLM.","journal-title":"Int J Nanomed"},{"key":"2860_CR24","doi-asserted-by":"publisher","unstructured":"Natsheh H, Touitou E. Phospholipid Vesicles for Dermal\/Transdermal and Nasal Administration of active molecules: the Effect of surfactants and alcohols on the fluidity of their lipid bilayers and Penetration Enhancement properties. Molecules. 2020;25(13). https:\/\/doi.org\/10.3390\/molecules25132959.","DOI":"10.3390\/molecules25132959"},{"issue":"11\u201312","key":"2860_CR25","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.addr.2013.08.002","volume":"65","author":"L Capretto","year":"2013","unstructured":"Capretto L, Carugo D, Mazzitelli S, Nastruzzi C, Zhang X. Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications. Adv Drug Deliv Rev. 2013;65(11\u201312):1496\u2013532. PubMedhttps:\/\/doi.org\/10.1016\/j.addr.2013.08.002.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2860_CR26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1039\/d1lc00812a","volume":"22","author":"F Tian","year":"2022","unstructured":"Tian F, Cai L, Liu C, Sun J. Microfluidic technologies for nanoparticle formation. Lab Chip. 2022;22(3):512\u201329. PubMedhttps:\/\/doi.org\/10.1039\/d1lc00812a.","journal-title":"Lab Chip"},{"key":"2860_CR27","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.2147\/IJN.S374736","volume":"17","author":"J Gao","year":"2022","unstructured":"Gao J, Li Z, Li J, Song P, Yang J, Xiao W, Li N, Xu R. Peptide-based HDL as an effective delivery system for lipophilic drugs to restrain Atherosclerosis Development. Int J Nanomed. 2022;17:3877\u201392. PubMedhttps:\/\/doi.org\/10.2147\/IJN.S374736.","journal-title":"Int J Nanomed"},{"key":"2860_CR28","doi-asserted-by":"crossref","unstructured":"Xu RD, Li SZ, Shi MF, Li ZY, Wang Y, Li J, Li Q, Klausen LH, Li A, Zhao HY et al. Peptide-based high-density lipoprotein promotes adipose tissue browning and restrains development of atherosclerosis and type 2 diabetes. Nano Today 2021, 36. DOI: ARTN 101054 1.10.1016\/j.nantod.2020.101054.","DOI":"10.1016\/j.nantod.2020.101054"},{"issue":"1","key":"2860_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s11418-022-01664-9","volume":"77","author":"Y Xiong","year":"2023","unstructured":"Xiong Y, Wang J, Wang S, Li H, Zhou X. Tryptanthrin ameliorates imiquimod-induced psoriasis in mice by suppressing inflammation and oxidative stress via NF-kappaB\/MAPK\/Nrf2 pathways. J Nat Med. 2023;77(1):188\u2013201. https:\/\/doi.org\/10.1007\/s11418-022-01664-9.","journal-title":"J Nat Med"},{"key":"2860_CR30","doi-asserted-by":"publisher","first-page":"152879","DOI":"10.1016\/j.phymed.2019.152879","volume":"58","author":"HN Chang","year":"2019","unstructured":"Chang HN, Yeh YC, Chueh HY, Pang JS. The anti-angiogenic effect of tryptanthrin is mediated by the inhibition of apelin promoter activity and shortened mRNA half-life in human vascular endothelial cells. Phytomedicine. 2019;58:152879. https:\/\/doi.org\/10.1016\/j.phymed.2019.152879.","journal-title":"Phytomedicine"},{"key":"2860_CR31","doi-asserted-by":"publisher","first-page":"100756","DOI":"10.1016\/j.mtbio.2023.100756","volume":"22","author":"P Wang","year":"2023","unstructured":"Wang P, Gao J, Guo S, Liu H, Cao C, Hong S, Sun Y, Wang C, Xiao W, Song P, et al. Benefits of topical indigo naturalis nanofibrous patch on psoriatic skin: a transdermal strategy for botanicals. Mater Today Bio. 2023;22:100756. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100756.","journal-title":"Mater Today Bio"},{"issue":"3","key":"2860_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s13346-020-00723-6","volume":"10","author":"JSR Viegas","year":"2020","unstructured":"Viegas JSR, Pra\u00e7a FG, Caron AL, Suzuki I, Silvestrini AVP, Medina WSG, Del Ciampo JO, Kravicz M, Bentley M. Nanostructured lipid carrier co-delivering tacrolimus and TNF-\u03b1 siRNA as an innovate approach to psoriasis. Drug Deliv Transl Res. 2020;10(3):646\u201360. https:\/\/doi.org\/10.1007\/s13346-020-00723-6. From NLM.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"2860_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1615\/critrevtherdrugcarriersyst.v20.i1.20","volume":"20","author":"B Godin","year":"2003","unstructured":"Godin B, Touitou E. Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst. 2003;20(1):63\u2013102. https:\/\/doi.org\/10.1615\/critrevtherdrugcarriersyst.v20.i1.20. From NLM.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"18","key":"2860_CR34","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/s0142-9612(00)00063-6","volume":"21","author":"N Dayan","year":"2000","unstructured":"Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials. 2000;21(18):1879\u201385. https:\/\/doi.org\/10.1016\/s0142-9612(00)00063-6.","journal-title":"Biomaterials"},{"key":"2860_CR35","doi-asserted-by":"publisher","first-page":"121226","DOI":"10.1016\/j.ijpharm.2021.121226","volume":"610","author":"K Sudhakar","year":"2021","unstructured":"Sudhakar K, Mishra V, Jain S, Rompicherla NC, Malviya N, Tambuwala MM. Development and evaluation of the effect of ethanol and surfactant in vesicular carriers on lamivudine permeation through the skin. Int J Pharm. 2021;610:121226. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121226.","journal-title":"Int J Pharm"},{"issue":"1","key":"2860_CR36","doi-asserted-by":"publisher","first-page":"10214","DOI":"10.1038\/s41598-021-89633-2","volume":"11","author":"FC Herrmann","year":"2021","unstructured":"Herrmann FC. Easy ultrastructural insight into the internal morphology of biological specimens by Atomic Force Microscopy. Sci Rep. 2021;11(1):10214. https:\/\/doi.org\/10.1038\/s41598-021-89633-2.","journal-title":"Sci Rep"},{"issue":"1","key":"2860_CR37","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1080\/10717544.2022.2072542","volume":"29","author":"W Sakran","year":"2022","unstructured":"Sakran W, Abdel-Rashid RS, Saleh F, Abdel-Monem R. Ethosomal gel for rectal transmucosal delivery of domperidone: design of experiment, in vitro, and in vivo evaluation. Drug Deliv. 2022;29(1):1477\u201391. https:\/\/doi.org\/10.1080\/10717544.2022.2072542. From NLM.","journal-title":"Drug Deliv"},{"key":"2860_CR38","doi-asserted-by":"publisher","first-page":"105341","DOI":"10.1016\/j.yrtph.2023.105341","volume":"138","author":"MA Pemberton","year":"2023","unstructured":"Pemberton MA, Kimber I. Propylene glycol, skin sensitisation and allergic contact dermatitis: a scientific and regulatory conundrum. Regul Toxicol Pharmacol. 2023;138:105341. https:\/\/doi.org\/10.1016\/j.yrtph.2023.105341. From NLM.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"3","key":"2860_CR39","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jare.2016.03.003","volume":"7","author":"SA Iizhar","year":"2016","unstructured":"Iizhar SA, Syed IA, Satar R, Ansari SA. In vitro assessment of pharmaceutical potential of ethosomes entrapped with terbinafine hydrochloride. J Adv Res. 2016;7(3):453\u201361. https:\/\/doi.org\/10.1016\/j.jare.2016.03.003. From NLM.","journal-title":"J Adv Res"},{"issue":"21","key":"2860_CR40","doi-asserted-by":"publisher","first-page":"19145","DOI":"10.1021\/acsomega.9b02435","volume":"4","author":"J Yan","year":"2019","unstructured":"Yan J, Zhu J, Cui M, Zhang J, Ma F, Su Y, Han X. Multifunctional Mineral hydrogels: potential in Artificially Intelligent skins and Drug Delivery. ACS Omega. 2019;4(21):19145\u201352. https:\/\/doi.org\/10.1021\/acsomega.9b02435. From NLM.","journal-title":"ACS Omega"},{"key":"2860_CR41","doi-asserted-by":"publisher","unstructured":"Gugleva V, Michailova V, Mihaylova R, Momekov G, Zaharieva MM, Najdenski H, Petrov P, Rangelov S, Forys A, Trzebicka B, et al. Formulation and evaluation of Hybrid Niosomal in situ gel for Intravesical Co-delivery of Curcumin and Gentamicin Sulfate. Pharmaceutics. 2022;14(4). https:\/\/doi.org\/10.3390\/pharmaceutics14040747. From NLM.","DOI":"10.3390\/pharmaceutics14040747"},{"issue":"3","key":"2860_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.119.3.493","volume":"119","author":"Y Gavrieli","year":"1992","unstructured":"Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119(3):493\u2013501. PubMed.","journal-title":"J Cell Biol"},{"key":"2860_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad399","author":"X Xie","year":"2023","unstructured":"Xie X, Cui Q, Jiang T, Zhao Z, Liu Z, Liu J, Yao Q, Wang Y, Dang E, Wang G, et al. A critical role of endothelial Skp2\/PTEN Axis in Angiogenesis and Psoriasis. Br J Dermatol. 2023. https:\/\/doi.org\/10.1093\/bjd\/ljad399.","journal-title":"Br J Dermatol"},{"issue":"2","key":"2860_CR44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/cbin.11492","volume":"45","author":"Q Han","year":"2021","unstructured":"Han Q, Niu X, Hou R, Li J, Liu Y, Li X, Li J, Li Y, Zhang K, Wu Y. Dermal mesenchymal stem cells promoted adhesion and migration of endothelial cells by integrin in psoriasis. Cell Biol Int. 2021;45(2):358\u201367. https:\/\/doi.org\/10.1002\/cbin.11492.","journal-title":"Cell Biol Int"},{"issue":"2","key":"2860_CR45","doi-asserted-by":"publisher","first-page":"100782","DOI":"10.1016\/j.ajps.2023.100782","volume":"18","author":"Q Yao","year":"2023","unstructured":"Yao Q, Zhai YY, He Z, Wang Q, Sun L, Sun T, Lv L, Li Y, Yang J, Lv D, et al. Water-responsive gel extends drug retention and facilitates skin penetration for curcumin topical delivery against psoriasis. Asian J Pharm Sci. 2023;18(2):100782. https:\/\/doi.org\/10.1016\/j.ajps.2023.100782.","journal-title":"Asian J Pharm Sci"},{"key":"2860_CR46","doi-asserted-by":"publisher","first-page":"112630","DOI":"10.1016\/j.eurpolymj.2023.112630","volume":"202","author":"T Vasowala","year":"2024","unstructured":"Vasowala T, Gharat S, Mhase M, Momin M. Advances in hydrogels based cutaneous drug delivery system for management of psoriasis. Eur Polymer J. 2024;202:112630. https:\/\/doi.org\/10.1016\/j.eurpolymj.2023.112630.","journal-title":"Eur Polymer J"},{"key":"2860_CR47","doi-asserted-by":"crossref","unstructured":"Hallan SS, Sguizzato M, Mariani P, Cortesi R, Huang N, Simeli\u00e8re F, Marchetti N, Drechsler M, Ruzgas T, Esposito E. Design and Characterization of Ethosomes for Transdermal Delivery of Caffeic Acid. Pharmaceutics 2020, 12 (8). DOI: 10.3390\/pharmaceutics12080740 From NLM.","DOI":"10.3390\/pharmaceutics12080740"},{"issue":"1\u20132","key":"2860_CR48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijpharm.2006.05.027","volume":"322","author":"MM Elsayed","year":"2006","unstructured":"Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm. 2006;322(1\u20132):60\u20136. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.05.027. From NLM.","journal-title":"Int J Pharm"},{"key":"2860_CR49","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.carbpol.2018.08.011","volume":"200","author":"SH Park","year":"2018","unstructured":"Park SH, Shin HS, Park SN. A novel pH-responsive hydrogel based on carboxymethyl cellulose\/2-hydroxyethyl acrylate for transdermal delivery of naringenin. Carbohydr Polym. 2018;200:341\u201352. https:\/\/doi.org\/10.1016\/j.carbpol.2018.08.011. From NLM.","journal-title":"Carbohydr Polym"},{"key":"2860_CR50","doi-asserted-by":"publisher","first-page":"105055","DOI":"10.1016\/j.chemphyslip.2021.105055","volume":"236","author":"S Knox","year":"2021","unstructured":"Knox S, O\u2019Boyle NM. Skin lipids in health and disease: a review. Chem Phys Lipids. 2021;236:105055. PubMedhttps:\/\/doi.org\/10.1016\/j.chemphyslip.2021.105055.","journal-title":"Chem Phys Lipids"},{"key":"2860_CR51","doi-asserted-by":"publisher","first-page":"961107","DOI":"10.3389\/fimmu.2022.961107","volume":"13","author":"M Simard","year":"2022","unstructured":"Simard M, Morin S, Ridha Z, Pouliot R. Current knowledge of the implication of lipid mediators in psoriasis. Front Immunol. 2022;13:961107. PubMedhttps:\/\/doi.org\/10.3389\/fimmu.2022.961107.","journal-title":"Front Immunol"},{"issue":"1","key":"2860_CR52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/bjd.16885","volume":"180","author":"I Snekvik","year":"2019","unstructured":"Snekvik I, Nilsen TIL, Romundstad PR, Saunes M. Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT study, Norway. Br J Dermatol. 2019;180(1):94\u20139. PubMedhttps:\/\/doi.org\/10.1111\/bjd.16885.","journal-title":"Br J Dermatol"},{"issue":"2","key":"2860_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2165\/00128071-200304020-00004","volume":"4","author":"L Coderch","year":"2003","unstructured":"Coderch L, L\u00f3pez O, de la Maza A, Parra JL. Ceramides and skin function. Am J Clin Dermatol. 2003;4(2):107\u201329. PubMed.","journal-title":"Am J Clin Dermatol"},{"key":"2860_CR54","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.plipres.2023.101264","volume":"93","author":"D Mijaljica","year":"2024","unstructured":"Mijaljica D, Townley JP, Spada F, Harrison IP. The heterogeneity and complexity of skin surface lipids in human skin health and disease. Prog Lipid Res. 2024;93:101264. PubMedhttps:\/\/doi.org\/10.1016\/j.plipres.2023.101264.","journal-title":"Prog Lipid Res"},{"issue":"3","key":"2860_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000464337","volume":"30","author":"EN Tessema","year":"2017","unstructured":"Tessema EN, Gebre-Mariam T, Neubert RHH, Wohlrab J. Potential applications of Phyto-Derived ceramides in improving epidermal barrier function. Skin Pharmacol Physiol. 2017;30(3):115\u201338. https:\/\/doi.org\/10.1159\/000464337. PubMed.","journal-title":"Skin Pharmacol Physiol"},{"issue":"1","key":"2860_CR56","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2019.12.002","volume":"97","author":"Q Li","year":"2020","unstructured":"Li Q, Fang H, Dang E, Wang G. The role of ceramides in skin homeostasis and inflammatory skin diseases. J Dermatol Sci. 2020;97(1):2\u20138. PubMedhttps:\/\/doi.org\/10.1016\/j.jdermsci.2019.12.002.","journal-title":"J Dermatol Sci"},{"key":"2860_CR57","doi-asserted-by":"publisher","unstructured":"Rudd AK, Devaraj NK, Rudd AK, Devaraj NK. Traceless synthesis of ceramides in living cells reveals saturation-dependent apoptotic effects. Proc Natl Acad Sci. 2018-7-17;115(29). https:\/\/doi.org\/10.1073\/pnas.1804266115.","DOI":"10.1073\/pnas.1804266115"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02860-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-02860-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02860-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T22:02:12Z","timestamp":1727474532000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-02860-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2860"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-02860-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"584"}}